MedPath

Alliance for Clinical Trials in Oncology

Alliance for Clinical Trials in Oncology logo
🇺🇸United States
Ownership
Private
Established
2011-01-01
Employees
251
Market Cap
-
Website
https://www.allianceforclinicaltrialsinoncology.org

Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

Phase 2
Completed
Conditions
Prostate Cancer
Interventions
First Posted Date
2003-01-27
Last Posted Date
2016-07-01
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
80
Registration Number
NCT00052845
Locations
🇺🇸

Walter Reed Army Medical Center, Washington, District of Columbia, United States

🇨🇦

McGill University, Montreal, Quebec, Canada

🇺🇸

Cedars-Sinai Comprehensive Cancer Center at Cedars-Sinai Medical Center, Los Angeles, California, United States

and more 77 locations

Oxaliplatin and Capecitabine in Treating Patients With Advanced Esophageal Cancer or Stomach Cancer

Phase 2
Completed
Conditions
Esophageal Cancer
Gastric Cancer
Interventions
First Posted Date
2003-01-27
Last Posted Date
2016-12-07
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
48
Registration Number
NCT00040859
Locations
🇺🇸

Mercy Medical Center - Sioux City, Sioux City, Iowa, United States

🇺🇸

Siouxland Hematology-Oncology Associates, LLP, Sioux City, Iowa, United States

🇺🇸

Avera Cancer Institute, Sioux Falls, South Dakota, United States

and more 3 locations

Combination Chemotherapy Plus Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma

Phase 2
Completed
Conditions
Lymphoma
Interventions
First Posted Date
2003-01-27
Last Posted Date
2016-12-07
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
58
Registration Number
NCT00005601
Locations
🇺🇸

CCOP - Illinois Oncology Research Association, Peoria, Illinois, United States

🇺🇸

CCOP - Iowa Oncology Research Association, Des Moines, Iowa, United States

🇺🇸

CCOP - Cedar Rapids Oncology Project, Cedar Rapids, Iowa, United States

and more 18 locations

Gemcitabine Plus Docetaxel in Treating Patients With Unresectable or Metastatic Liver Cancer

Phase 2
Completed
Conditions
Liver Cancer
Interventions
First Posted Date
2003-01-27
Last Posted Date
2016-12-07
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
25
Registration Number
NCT00006010
Locations
🇺🇸

CCOP - Atlanta Regional, Atlanta, Georgia, United States

🇺🇸

CCOP - Carle Cancer Center, Urbana, Illinois, United States

🇺🇸

Siouxland Hematology-Oncology, Sioux City, Iowa, United States

and more 14 locations

Docetaxel and St. John's Wort in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery

Phase 3
Withdrawn
Conditions
Adult Solid Tumor
Breast Cancer
Head and Neck Cancer
Kidney and Urinary Cancer
Male Reproductive Cancer
Thorax and Respiratory Cancer
Interventions
Drug: Hypericum perforatum
Other: placebo
First Posted Date
2003-01-27
Last Posted Date
2016-07-12
Lead Sponsor
Alliance for Clinical Trials in Oncology
Registration Number
NCT00041171

Vinorelbine in Treating Older Women With Stage IV Breast Cancer

Phase 2
Completed
Conditions
Breast Cancer
Interventions
First Posted Date
2003-01-27
Last Posted Date
2016-07-06
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
25
Registration Number
NCT00022152
Locations
🇺🇸

CCOP - Duluth, Duluth, Minnesota, United States

🇺🇸

Altru Health Systems, Grand Forks, North Dakota, United States

🇺🇸

CentraCare Health Plaza, Saint Cloud, Minnesota, United States

and more 15 locations

Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma

First Posted Date
2003-01-27
Last Posted Date
2016-07-14
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
91
Registration Number
NCT00006029
Locations
🇺🇸

Memorial Regional Hospital Comprehensive Cancer Center, Hollywood, Florida, United States

🇺🇸

University of Chicago Cancer Research Center, Chicago, Illinois, United States

🇺🇸

Fort Wayne Medical Oncology and Hematology, Incorporated, Fort Wayne, Indiana, United States

and more 73 locations

Acitretin in Preventing Skin Cancers in Patients With Previously Treated Skin Cancers Who Have Undergone Organ Transplantation

Not Applicable
Completed
Conditions
Non-melanomatous Skin Cancer
Interventions
Other: placebo
First Posted Date
2003-01-27
Last Posted Date
2016-07-13
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
129
Registration Number
NCT00003611
Locations
🇺🇸

CentraCare Health Plaza, Saint Cloud, Minnesota, United States

🇺🇸

CCOP - Wichita, Wichita, Kansas, United States

🇺🇸

CCOP - Carle Cancer Center, Urbana, Illinois, United States

and more 8 locations

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Pancreatic Cancer

Phase 2
Completed
Conditions
Pancreatic Cancer
Interventions
First Posted Date
2003-01-27
Last Posted Date
2016-07-14
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
48
Registration Number
NCT00026403
Locations
🇺🇸

Altru Cancer Center, Grand Forks, North Dakota, United States

🇺🇸

Allegheny General Hospital, Pittsburgh, Pennsylvania, United States

🇺🇸

Mayo Clinic Cancer Center, Rochester, Minnesota, United States

and more 23 locations

Combination Chemotherapy Plus Fluoxetine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer

Phase 2
Completed
Conditions
Anxiety Disorder
Fatigue
Lung Cancer
Depression
Interventions
First Posted Date
2003-01-27
Last Posted Date
2016-07-04
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
21
Registration Number
NCT00005850
Locations
🇺🇸

Memorial Regional Hospital Comprehensive Cancer Center, Hollywood, Florida, United States

🇺🇸

Helen and Harry Gray Cancer Institute at Good Samaritan Medical Center, West Palm Beach, Florida, United States

🇺🇸

Fort Wayne Medical Oncology and Hematology, Incorporated, Fort Wayne, Indiana, United States

and more 40 locations
© Copyright 2025. All Rights Reserved by MedPath